1. Home
  2. FULT vs RARE Comparison

FULT vs RARE Comparison

Compare FULT & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FULT
  • RARE
  • Stock Information
  • Founded
  • FULT 1882
  • RARE 2010
  • Country
  • FULT United States
  • RARE United States
  • Employees
  • FULT N/A
  • RARE N/A
  • Industry
  • FULT Major Banks
  • RARE Biotechnology: Pharmaceutical Preparations
  • Sector
  • FULT Finance
  • RARE Health Care
  • Exchange
  • FULT Nasdaq
  • RARE Nasdaq
  • Market Cap
  • FULT 3.3B
  • RARE 3.2B
  • IPO Year
  • FULT N/A
  • RARE 2014
  • Fundamental
  • Price
  • FULT $18.40
  • RARE $33.76
  • Analyst Decision
  • FULT Hold
  • RARE Strong Buy
  • Analyst Count
  • FULT 4
  • RARE 15
  • Target Price
  • FULT $20.75
  • RARE $85.20
  • AVG Volume (30 Days)
  • FULT 1.5M
  • RARE 1.4M
  • Earning Date
  • FULT 10-21-2025
  • RARE 11-04-2025
  • Dividend Yield
  • FULT 3.95%
  • RARE N/A
  • EPS Growth
  • FULT 20.91
  • RARE N/A
  • EPS
  • FULT 1.91
  • RARE N/A
  • Revenue
  • FULT $1,230,470,000.00
  • RARE $630,598,000.00
  • Revenue This Year
  • FULT N/A
  • RARE $19.65
  • Revenue Next Year
  • FULT N/A
  • RARE $23.65
  • P/E Ratio
  • FULT $9.55
  • RARE N/A
  • Revenue Growth
  • FULT 9.56
  • RARE 20.63
  • 52 Week Low
  • FULT $14.33
  • RARE $25.81
  • 52 Week High
  • FULT $22.01
  • RARE $50.00
  • Technical
  • Relative Strength Index (RSI)
  • FULT 58.78
  • RARE 55.06
  • Support Level
  • FULT $17.00
  • RARE $32.06
  • Resistance Level
  • FULT $18.51
  • RARE $34.21
  • Average True Range (ATR)
  • FULT 0.49
  • RARE 1.51
  • MACD
  • FULT 0.12
  • RARE 0.05
  • Stochastic Oscillator
  • FULT 93.44
  • RARE 91.24

About FULT Fulton Financial Corporation

Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.

About RARE Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.

Share on Social Networks: